Covid-19 Vaccines — Immunity, Variants, Boosters | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …

SARS-CoV-2 is primarily an airborne infection of the upper respiratory tract, which on
reaching the lungs causes the severe acute respiratory disease, COVID-19. Its first contact …

An outbreak of over 1,000 COVID-19 cases in Provincetown, Massachusetts (MA), in July
2021—the first large outbreak mostly in vaccinated individuals in the US—prompted a …

ABSTRACT Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spread worldwide. Many variants of SARS-CoV …

Testing for SARS-CoV-2 is one of the most important assets in COVID-19 management and
mitigation. At the onset of the pandemic, SARS-CoV-2 testing was uniquely performed in …

Abstract Chlorella spp., Spirulina spp., and fucoidan dry powders, are commercialized as
food supplements and are considered safe for human consumption. Their broad-spectrum …

We sought to assess breakthrough SARS-CoV-2 infections in vaccinated individuals by
variant distribution and to identify the common risk associations. The PubMed, Web of …

Abstract Background Puerto Rico has experienced the full impact of the COVID-19
pandemic. Since SARS-CoV-2, the virus that causes COVID-19, was first detected on the …

With COVID‐19 moving toward an endemic phase, it is worthwhile to identify lessons from
the pandemic that can promote the effective strengthening of national health systems. We …

SARS-CoV-2, the causative agent of COVID-19, is known to be transmitted by respiratory
droplets and aerosols. Since the virus is shed at high concentrations in respiratory …